Literature DB >> 9870955

Neuronal degeneration in canine narcolepsy.

J M Siegel1, R Nienhuis, S Gulyani, S Ouyang, M F Wu, E Mignot, R C Switzer, G McMurry, M Cornford.   

Abstract

Narcolepsy is a lifelong illness characterized by persistent sleepiness, hypnagogic hallucinations, and episodes of motor paralysis called cataplexy. We have tested the hypothesis that a transient neurodegenerative process is linked to symptom onset. Using the amino-cupric silver stain on brain sections from canine narcoleptics, we found elevated levels of axonal degeneration in the amygdala, basal forebrain (including the nucleus of the diagonal band, substantia innominata, and preoptic region), entopeduncular nucleus, and medial septal region. Reactive neuronal somata, an indicator of neuronal pathology, were found in the ventral amygdala. Axonal degeneration was maximal at 2-4 months of age. The number of reactive cells was maximal at 1 month of age. These degenerative changes precede or coincide with symptom onset. The forebrain degeneration that we have observed can explain the major symptoms of narcolepsy.

Entities:  

Mesh:

Year:  1999        PMID: 9870955      PMCID: PMC6782381     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  55 in total

1.  Autoimmune diseases: the failure of self tolerance.

Authors:  A A Sinha; M T Lopez; H O McDevitt
Journal:  Science       Date:  1990-06-15       Impact factor: 47.728

2.  Forebrain activation in REM sleep: an FDG PET study.

Authors:  E A Nofzinger; M A Mintun; M Wiseman; D J Kupfer; R Y Moore
Journal:  Brain Res       Date:  1997-10-03       Impact factor: 3.252

3.  Sleep suppression following kainic acid-induced lesions of the basal forebrain.

Authors:  R Szymusiak; D McGinty
Journal:  Exp Neurol       Date:  1986-12       Impact factor: 5.330

4.  Sleep-related neuronal discharge in the basal forebrain of cats.

Authors:  R Szymusiak; D McGinty
Journal:  Brain Res       Date:  1986-04-02       Impact factor: 3.252

5.  Genetic linkage of autosomal recessive canine narcolepsy with a mu immunoglobulin heavy-chain switch-like segment.

Authors:  E Mignot; C Wang; C Rattazzi; C Gaiser; M Lovett; C Guilleminault; W C Dement; F C Grumet
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

6.  Pallidal and entopeduncular single unit activity in cats during drinking.

Authors:  T I Lidsky
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1975-07

7.  Narcolepsy in a Brahman bull.

Authors:  G M Strain; B M Olcott; R M Archer; B K McClintock
Journal:  J Am Vet Med Assoc       Date:  1984-09-01       Impact factor: 1.936

8.  Pharmacologic and psychotherapeutic issues in coexistent paranoid schizophrenia and narcolepsy: case report.

Authors:  R J Cadieux; J D Kales; A Kales; J Biever; L D Mann
Journal:  J Clin Psychiatry       Date:  1985-05       Impact factor: 4.384

Review 9.  Narcolepsy and immunity.

Authors:  E Mignot; M Tafti; W C Dement; F C Grumet
Journal:  Adv Neuroimmunol       Date:  1995

10.  Neuronal activity in narcolepsy: identification of cataplexy-related cells in the medial medulla.

Authors:  J M Siegel; R Nienhuis; H M Fahringer; R Paul; P Shiromani; W C Dement; E Mignot; C Chiu
Journal:  Science       Date:  1991-05-31       Impact factor: 47.728

View more
  21 in total

Review 1.  Orexin/hypocretin modulation of the basal forebrain cholinergic system: Role in attention.

Authors:  J Fadel; J A Burk
Journal:  Brain Res       Date:  2009-08-21       Impact factor: 3.252

Review 2.  Control of sleep and wakefulness.

Authors:  Ritchie E Brown; Radhika Basheer; James T McKenna; Robert E Strecker; Robert W McCarley
Journal:  Physiol Rev       Date:  2012-07       Impact factor: 37.312

3.  Aging-related deficits in orexin/hypocretin modulation of the septohippocampal cholinergic system.

Authors:  Emily M Stanley; Jim Fadel
Journal:  Synapse       Date:  2012-02-15       Impact factor: 2.562

4.  Intravenously administered hypocretin-1 alters brain amino acid release: an in vivo microdialysis study in rats.

Authors:  Joshi John; Ming-Fung Wu; Tohru Kodama; Jerome M Siegel
Journal:  J Physiol       Date:  2003-03-07       Impact factor: 5.182

5.  Role of the hypocretin (orexin) receptor 2 (Hcrt-r2) in the regulation of hypocretin level and cataplexy.

Authors:  Ming-Fung Wu; Robert Nienhuis; Nigel Maidment; Hoa A Lam; Jerome M Siegel
Journal:  J Neurosci       Date:  2011-04-27       Impact factor: 6.167

6.  Evidence for metabolic hypothalamo-amygdala dysfunction in narcolepsy.

Authors:  Rositsa Poryazova; Betina Schnepf; Esther Werth; Ramin Khatami; Ulrike Dydak; Dieter Meier; Peter Boesiger; Claudio L Bassetti
Journal:  Sleep       Date:  2009-05       Impact factor: 5.849

7.  Developmental changes in CSF hypocretin-1 (orexin-A) levels in normal and genetically narcoleptic Doberman pinschers.

Authors:  Joshi John; Ming-Fung Wu; Nigel T Maidment; Hoa A Lam; Lisa N Boehmer; Melanie Patton; Jerome M Siegel
Journal:  J Physiol       Date:  2004-08-12       Impact factor: 5.182

8.  Animal models of narcolepsy.

Authors:  Lichao Chen; Ritchie E Brown; James T McKenna; Robert W McCarley
Journal:  CNS Neurol Disord Drug Targets       Date:  2009-08       Impact factor: 4.388

Review 9.  Hypocretin (orexin): role in normal behavior and neuropathology.

Authors:  Jerome M Siegel
Journal:  Annu Rev Psychol       Date:  2004       Impact factor: 24.137

10.  Treatment with immunosuppressive and anti-inflammatory agents delays onset of canine genetic narcolepsy and reduces symptom severity.

Authors:  L N Boehmer; M-F Wu; J John; J M Siegel
Journal:  Exp Neurol       Date:  2004-08       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.